Sabra Q1 Normalized FFO $0.34, AFFO $0.35; reiterates FY guidance; $0.30 dividend

Sabra Health Care REIT, Inc.

2024-Q1 EPS reported $0.11 revenue$166,747,000

Q1 per diluted share: Net income $0.11, Normalized FFO $0.34, AFFO $0.35.
EBITDARM coverage: Skilled Nursing 1.79x (excl. PRF), Senior Housing Leased 1.33x, Behavioral 3.77x.
Board declared $0.30 quarterly dividend payable May 31, 2024 to holders of record May 20.
Reiterated FY2024 guidance: Normalized FFO $1.34-$1.38, AFFO $1.38-$1.42, Net Income $0.53-$0.57.
Liquidity $913.8M ($59.9M cash + $853.9M revolver); $500M ATM; CEO expects new investments in Q2 call.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Sabra Health Care REIT, Inc. updated its the three month period ended March 31, 2024 guidance (reaffirmed).

Period: the three month period ended March 31, 2024
Guidance: reaffirmed
Result: reported results

Exact text from the filing

On May 8, 2024, Sabra Health Care REIT, Inc. (“Sabra”) issued a press release reporting its results of operations for the three month period ended March 31, 2024.

View on SEC.gov

1436 earnings releases filed in the last 30 days. Browse all earnings releases →

Sabra Health Care REIT, Inc. filing history →

Source: SEC EDGAR

accession 0001492298-24-000013

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.